Alternate Splicing of the p53 Inhibitor HDMX Offers a...

Cancer Research 2012 / 08 Vol. 72; Iss. 16

Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer

Lenos, K., Grawenda, A. M., Lodder, K., Kuijjer, M. L., Teunisse, A. F. A. S., Repapi, E., Grochola, L. F., Bartel, F., Hogendoorn, P. C. W., Wuerl, P., Taubert, H., Cleton-Jansen, A.-M., Bond, G. L.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.can-12-0215
Date:
August, 2012
File:
PDF, 903 KB
english, 2012
Conversion to is in progress
Conversion to is failed